Technology ID
TAB-4977
Implications for Mammalian Gene Regulation and Disease Pathogenesis
E-Numbers
E-195-2011-0
Lead Inventor
Lenardo, Michael
Lead IC
NIAID
Co-Inventors
Wan, Feng-Yi
ICs
NIAID
Applications
Therapeutics
Research Materials
Diagnostics
Therapeutic Areas
Rare/Neglected Diseases
Oncology
Infectious Disease
Immunology
Development Stages
Discovery
Research Products
Antibodies
The discovery of RPS3 and phospho-RPS3 antibodies represents a significant advancement in understanding mammalian gene regulation and its implications for disease. These antibodies serve as critical tools for detecting and studying the NF-kB transcription factor, particularly its specifier subunit RPS3 and its phosphorylated form. By enabling the precise identification and localization of these regulatory proteins, this technology opens avenues for investigating their roles in various diseases, including cancer and immune disorders. This discovery provides a foundation for further research and potential therapeutic applications targeting these pathways.
Commercial Applications
The RPS3 and phospho-RPS3 antibodies hold immense potential for various applications in both research and clinical settings. In research, these antibodies can be used to elucidate the role of the NF-kB transcription factor in different disease processes, such as cancer and immune disorders. They can also aid in understanding the mechanisms underlying gene regulation and cell signaling pathways. Furthermore, these antibodies may have diagnostic utility, potentially serving as biomarkers for diseases associated with dysregulated NF-kB signaling. Additionally, the antibodies could be utilized in drug discovery efforts, facilitating the development of novel therapeutics targeting NF-kB-related pathways. Overall, the applications of these antibodies are diverse and far-reaching, making them valuable tools in advancing our understanding and treatment of various diseases.
Competitive Advantages
The RPS3 and phospho-RPS3 antibodies offer several competitive advantages over existing technologies. Firstly, they provide a high level of specificity and sensitivity in detecting these key regulatory proteins, allowing for precise and reliable measurements in various biological samples. Additionally, these antibodies offer versatility, as they can be used in a wide range of applications, including Western blotting, immunofluorescence, and immunoprecipitation assays. Furthermore, their ability to detect both the regulator and its phosphorylated form provides a comprehensive understanding of the protein's function and localization within cells. This comprehensive approach sets these antibodies apart from other tools currently available in the field, making them invaluable for researchers studying gene regulation and its role in disease.
Licensing Contact: